ETON
Eton Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$865.33M
P/E Ratio
—
EPS
$-0.06
Beta
0.89
52W High
$35.66
52W Low
$13.09
50-Day MA
$28.39
200-Day MA
$20.41
Dividend Yield
—
Profit Margin
-1.70%
Forward P/E
46.51
PEG Ratio
—
About Eton Pharmaceuticals Inc
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park, Illinois.
Fundamentals
| Revenue (TTM) | $86.93M |
| Gross Profit (TTM) | $51.92M |
| EBITDA | $11.09M |
| Operating Margin | 11.40% |
| Return on Equity | -5.36% |
| Return on Assets | 4.76% |
| Revenue/Share (TTM) | $3.22 |
| Book Value | $1.12 |
| Price-to-Book | 28.26 |
| Price-to-Sales (TTM) | 9.95 |
| EV/Revenue | 10.09 |
| EV/EBITDA | 141.38 |
| Quarterly Earnings Growth (YoY) | -12.60% |
| Quarterly Revenue Growth (YoY) | 40.40% |
| Shares Outstanding | $27.39M |
| Float | $21.13M |
| % Insiders | 4.45% |
| % Institutions | 65.39% |
Historical Volatility
HV 10-Day
54.70%
HV 20-Day
61.67%
HV 30-Day
75.77%
HV 60-Day
71.19%
HV Rank
91.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($45.67 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026